用声音治疗听力损失。俄语中有句话叫klin klinom：以楔驱楔。问题本身成为治疗手段。
每种基因治疗载体都需要一个启动子：告诉细胞何时合成蛋白质的开关。标准方法是持续开启。我们的方案：将基因置于一个响应声音的开关后面。毛细胞已经具备这种机制。声音使静纤毛弯曲，钙离子涌入，信号级联启动。我们加以利用。有声音 = 基因开启。安静 = 基因关闭。孩子佩戴他已有的助听器，无需特殊频率，只是日常声音。
蛋白质会在夜间消失吗？不会。立体纤毛蛋白的半衰期约为30天。达到正常水平50%大约需要13小时的助听器使用时间。睡眠不会重置任何东西。
The ODE model is mathematically correct: equations are sound, parameters are from peer-reviewed literature, and the system dynamics are thoroughly analyzed. However, several biological assumptions have not been validated in cochlear outer hair cells. A literature review (April 2026) identified the following critical gaps.
A more biologically plausible activity-dependent pathway exists. Adenylyl cyclase 1 (AC1/ADCY1) is a calcium-calmodulin-activated enzyme located directly in stereocilia, where MET-channel calcium is abundant. It converts Ca²⁺ signals to cAMP, a small molecule that diffuses freely to the soma, bypassing the calcium compartmentalization barrier entirely.
| NFAT pathway | AC1/CREB pathway | |
|---|---|---|
| Ca²⁺ sensor location | Soma (Ca²⁺ doesn't reach) | Stereocilia (where Ca²⁺ is) |
| Second messenger | Ca²⁺ itself (heavily buffered) | cAMP (freely diffusing) |
| Pathway in OHC | Only activated by damage | AC1 mutations cause deafness |
| Safety | Triggers apoptosis (TNF, Caspases) | Neuroplasticity pathway |
| Promoter element | 6xNFAT-RE (never tested in ear) | CRE (TGACGTCA, well characterized) |
| Tested in hair cells | No | No |
In Strc-/- mice, stereocilia lose horizontal top connectors by P15, bundle stiffness drops 60-74%, and stereocilia progressively disconnect. It is possible that this structural disorganization disrupts calcium compartmentalization, allowing MET-channel Ca²⁺ to leak into the soma, making the NFAT pathway viable only in DFNB16 cells.
If true, this would create an elegant self-dosing mechanism: the disease activates the promoter, the cure silences it. But no one has measured somatic Ca²⁺ in Strc-/- OHCs. This remains pure speculation. It is testable by calcium imaging in cochlear explants from stereocilin-null mice.
这是一个计算假设。每个单独组件均已得到验证（NFAT启动子、MET通道生物物理学、mini-STRC包装）。目前尚无人将它们结合用于内耳基因治疗。
空话廉价。我们建立了一个数学模型来验证这一级联是否真的能产生足够的蛋白质。五个微分方程，每个参数均来自已发表文献，测试了四种情景。问题是：佩戴助听器的孩子能否仅通过声音产生治疗性水平的立体纤毛蛋白？
在现实的助听器使用时间表下（70 dB开启16小时，睡眠8小时），模型预测72小时后每个OHC中有29,571个立体纤毛蛋白分子（目标：15,000个）。在安静环境中，仅积累1,023个分子（6.8%）。这在声音激活和静默状态之间提供了29倍动态范围。仅需13小时助听器使用即可达到50%治疗阈值。系统自我调节：蛋白质在静纤毛上的可用结合位点处达到饱和，防止过度表达。
The system saturates at ~20 dB. Between 22 dB (quiet bedroom) and 70 dB (hearing aid), protein output is identical: ~29,750 molecules. The 29x dynamic range exists only between 0 and 14 dB, a range humans rarely experience. Self-dosing via hearing aid gain modulation does not work with the current 6xNFAT promoter.
All 5 eigenvalues at 70 dB have negative real parts. System is asymptotically stable. No oscillations, no chaos. Five timescales: Ca²⁺ (seconds), NFAT cycling (minutes), mRNA (hours), protein (days).
Path-dependence detected due to slow protein degradation (t½ = 30 days). Kinetic memory, not bistability. One steady state per parameter set. System is monostable.
Parameter optimization across 245 combinations found that increasing the NFAT activation threshold (0.05→0.30) and cooperativity (Hill 4→8) moves the switch to 40-50 dB. Biologically: use 9 NFAT binding sites with reduced individual affinity (A→G at position 4 of each site). One nucleotide change, repeated 9 times, transforms the therapy from "always ON" to "hearing-aid controlled."
| Sound | 6xNFAT (current) | 9xNFAT-weak |
|---|---|---|
| 0 dB | 11.6% | 0.1% |
| 20 dB | 179.7% | 0.1% |
| 40 dB | 198.3% | 5.7% |
| 45 dB | ~198% | 51.2% |
| 50 dB | 198.3% | 163.3% |
| 70 dB | 198.3% | 198.1% |
Full bifurcation analysis: Jacobian eigenvalues at 0/70/90 dB, two-parameter sweep (Kd_CaN × NFAT_threshold, 90 points), hysteresis check (ramp up vs down over 72h), and promoter fold-induction sensitivity (10×-200×). All passed. Code: bifurcation_analysis.py
Previous ODE models used fixed sound profiles. This model closes the feedback loop: protein accumulates → hearing improves → audiologist reduces hearing aid gain → less MET activation → less STRC production → equilibrium. The hearing aid becomes a true dosing device.
Day 3: Hearing improves enough that HA adds zero gain. System reaches equilibrium at 27,617 molecules (184% of target), 3.1 dB residual hearing loss, maintained by ambient sound alone.
The promoters behave identically under normal conditions. The difference appears when sound is removed. This is the test of real self-dosing.
9x responds to silence. 6x doesn't.
One half-life. Full recovery in 2 weeks.
9x needs real sound. 6x is constitutive.
| 参数 | 数值 | 来源 |
|---|---|---|
| MET channel conductance | 150 pS | Beurg et al. 2006 |
| Channels per bundle | 134 | Fettiplace 2017 |
| Endolymphatic potential | +80 mV | Standard |
| Calcineurin Kd (Ca²⁺) | 500 nM | Stemmer & Klee 1994 |
| NFAT nuclear import t½ | ~2 min | Tomida et al. 2003 |
| Promoter fold induction | up to 62x | Wu et al. 2023 |
| Promoter leakage | Zero (3 weeks) | Wu et al. 2023 |
| Apical compartment volume | 0.05 pL | Lumpkin & Bhatt 2001 |
结果有多脆弱？我们将每个参数变化±50%，找出最关键的因素。如果一个数字改变时模型失效，该参数就需要最仔细的实验测量。
转录和翻译速率占主导地位（灵敏度1.50）。这意味着最重要的实验是专门表征毛细胞中6xNFAT启动子的强度。通道数量和钙调磷酸酶亲和力的影响较小：系统对这些参数的生物变异具有鲁棒性。